Pregled bibliografske jedinice broj: 677393
Powder form and stability of Pluronic mixed micelle dispersions for drug delivery applications.
Powder form and stability of Pluronic mixed micelle dispersions for drug delivery applications. // Drug development and industrial pharmacy, 40 (2013), 7; 944-951 doi:10.3109/03639045.2013.791831 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 677393 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Powder form and stability of Pluronic mixed micelle dispersions for drug delivery applications.
Autori
Pepić, Ivan ; Lovrić, Jasmina ; Hafner, Anita ; Filipović-Grčić, Jelena
Izvornik
Drug development and industrial pharmacy (0363-9045) 40
(2013), 7;
944-951
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Mixed Pluronic micelles; Pluronic F127; Pluronic L121; powder form; stability
Sažetak
The aim of this work was to optimize a formulation of the Pluronic® F127/L121 mixed micelle system and evaluate it in terms of stability upon dilution in biologically relevant media and to explore the possibility of preparing F127/L121 micelles in a powder form that can be simply reconstituted to an initial freshly made mixed micelle formulation. The mixed F127/L121 micelles were prepared at a relatively high concentration of Pluronics (1% w/w for both Pluronics) using two different methods (direct dissolution and film rehydration) with an external input of energy. The optimal preparation of the mixed F127/L121 micelles (hydrodynamic diameter (dh) = 75 nm, polydispersity index (PDI) = 0.287) was achieved using the film rehydration method followed by ultrasonication. Stability studies of the F127/L121 micelle system were performed at 25 °C and 37 °C and upon dilution in different biologically relevant media. The F127/L121 micelles were stable in phosphate buffered saline (PBS) upon 100-fold dilution for at least 10 d and in PBS containing bovine serum albumin upon 10 and 50-fold dilution for at least 48 and 12 h, respectively. A dry powdered form of the mixed micelles was prepared by freeze-drying after slow or fast freezing process. The influence of the type and amount of cryoprotectant on the prevention of F127/L121 micelles aggregation during the freeze-drying and reconstitution processes were evaluated. The use of trehalose (5%, w/w) and sucrose (2.5%, w/w) with slow and fast freezing process, respectively, resulted in a reconstituted product with mostly similar dh and PDI values of the fresh micelle formulation.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija
POVEZANOST RADA
Projekti:
006-0061117-1244 - Terapijski nanosustavi (Filipović-Grčić, Jelena, MZOS ) ( CroRIS)
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE